Atogepant

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 201 publications

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Journal: Neurology

Published: August 31, 2026

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

Journal: Headache

Published: July 29, 2026

Safety and Efficacy of Atogepant for Migraine Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Safety and Efficacy of Atogepant for Migraine Prevention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: Cureus

Published: July 19, 2026

Manipulating the Activity and Diastereoselectivity of ω-Transaminase for the Synthesis of Bulky Aminopiperidines with Contiguous Stereocenters.

Manipulating the Activity and Diastereoselectivity of ω-Transaminase for the Synthesis of Bulky Aminopiperidines with Contiguous Stereocenters.

Journal: Organic letters

Published: July 02, 2026

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

Journal: Cephalalgia : an international journal of headache

Published: June 26, 2026

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Journal: Neurology

Published: May 06, 2026

Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.

Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.

Journal: Annals of internal medicine

Published: May 04, 2026

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.

Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.

Journal: The journal of headache and pain

Published: April 21, 2026

Effectiveness and tolerability of pharmacological prophylaxis in migraine patients with prior preventive treatment failure: A systematic review and network meta-analysis of randomized controlled trials.

Effectiveness and tolerability of pharmacological prophylaxis in migraine patients with prior preventive treatment failure: A systematic review and network meta-analysis of randomized controlled trials.

Journal: Cephalalgia : an international journal of headache

Published: April 21, 2026

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

Journal: Neurology and therapy

Published: April 08, 2026

Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.

Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.

Journal: Cephalalgia : an international journal of headache

Published: April 07, 2026

Atogepant for migraine in real-world clinical practice: Insights from a large multicentre study in a treatment-resistant population (GEMA project).

Atogepant for migraine in real-world clinical practice: Insights from a large multicentre study in a treatment-resistant population (GEMA project).

Journal: Cephalalgia : an international journal of headache

Published: April 01, 2026

Showing 1-12 of 201

Last Updated: 09/26/2026